Omega Therapeutics Inc (OMGA) Financials

$0.05

$0.00 (7.78%)

As on 28-Apr-2025 09:30EDT

Market cap

$8 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	8.10	3.09	2.07	0.14	--	--
Cost of Revenue	12.94	65.87	5.19	1.39	1.15	0.79
Gross Profit	-4.84	-62.78	2.07	-1.24	-1.15	-0.79
Operating Expenses	78.65	103.36	104.84	66.18	28.65	17.34
Operating Profit (EBIT)	-74.15	-100.26	-102.77	-66.03	-28.65	-17.34
Other Income	--	--	-0.16	-1.34	--	--
Profit before Tax	-73.09	-97.43	-102.70	-68.28	-29.45	-17.95
Provision for Tax	5.81	6.60	-0.07	0.88	0.75	0.58
Profit after Tax (Net Income)	-73.09	-97.43	-102.64	-69.16	-30.20	-18.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-102.70	-68.28	-29.45	-17.95

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	11.54	58.02	105.97	200.63	-64.63	-35.92
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	117.01	119.54	18.06	20.72	85.01	39.81
Current Liabilities	24.17	26.81	21.96	11.98	7.70	2.23
Total Liabilities	176.90	204.37	146.00	233.33	28.08	6.12

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	113.77	114.48	21.32	4.05	4.08	3.47
Current Assets	38.95	89.88	124.68	229.29	24.00	2.65
Total Assets	176.90	204.37	146.00	233.33	28.08	6.12
Total Debt*	128.13	128.43	22.58	19.87	11.73	11.89
Net Current Assets	14.78	63.08	115.63	217.30	16.30	0.43

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-91.51	-98.52	-57.61	-26.13	-15.68
Cash Flow from Investing Activities	--	--	-18.06	-40.40	-1.81	-0.89
Cash from Financing Activities	--	41.82	0.71	261.54	48.62	11.99
Net Cash Inflow / Outflow	--	--	-115.87	163.53	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-61.86	-58.81	-82.53	78.52	--
ROE (%)	-276.36	-118.82	-66.95	-101.71	60.07	--
ROA (%)	-34.68	-55.62	-54.11	-52.91	-176.59	--
EBIT Margin (%)	-703.19	-3,240.50	-4,957.36	-45,855.56	--	--
Net Margin (%)	-902.93	-3,148.93	-5,356.78	5,792.46	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	184.93	0.49	13.40	--	--	--
EBIT Growth (%)	48.43	2.44	-55.63	-130.52	-65.21	--
Net Profit Growth (%)	31.48	5.07	-48.40	-129.02	-62.98	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.23	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.12	-0.59	1.05	3.18	--	--
Close Price ($)	1.22	3.01	5.71	11.33	--	--
High Price ($)	6.30	11.98	14.31	31.41	--	--
Low Price ($)	1.19	1.30	1.98	11.30	--	--
Market Cap ($ Cr)	7.90	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	1.00	2.21	0.21	0.10	-0.18	-0.33
Short term debt to equity ratio	1.38	0.26	0.06	--	-0.05	--
Current Ratio	1.61	3.35	5.68	19.13	3.12	1.19
Quick Ratio	1.61	3.34	3.80	19.16	--	--
Interest Coverage	-30.46	--	-462.91	-72.56	-36.87	-29.14

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	6.00	225.79	86.73	361.81	--	--
Asset Turnover	0.04	0.02	0.01	0.00	--	--
Receivable days	--	518.48	204.30	905.52	--	--
Inventory Days	--	114.93	1,438.73	-69.52	--	--
Payable days	--	13.11	183.54	417.65	315.53	421.83
Cash Conversion Cycle	--	620.31	1,459.48	418.34	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.